News

Topiramate May Reduce Frequency of Binge Eating


 

Obese patients with binge-eating disorder treated with topiramate in an open-label study binged significantly less often and lost weight, according to a study by Susan L. McElroy, M.D., and her colleagues.

A previous, randomized, placebo-controlled trial of 61 patients conducted by Dr. McElroy and her coinvestigators reported that topiramate (Topamax) reduced both binge-eating behavior and body weight in obese patients suffering from binge-eating disorder (BED). That study lasted 14 weeks (Am. J. Psychiatry 2003;160:255–61).

To assess topiramate's effectiveness and tolerability over a longer period, the investigators extended the study for an additional 42 weeks in subjects who completed the first study and wanted to pursue treatment with the drug. The 42-week extension was open-label, nonrandomized, and uncontrolled (J. Clin. Psychiatry 2004;65:1463–9).

Fifteen patients who received topiramate during the controlled study and participated in the extension study showed an average drop of 4.0 binges per week, compared with their binge frequency before they started taking the drug (P < .001), and lost 14.1 kg in weight (P = .023), compared with their baseline weight. Sixteen patients who received placebo during the controlled study and participated in the extension study showed a drop of 2.5 binges per week (P < .044), compared with their baseline rate, and lost 14.5 kg (P < .002), the researchers reported. Topiramate's mechanism of action in BED is unknown, but the investigators speculated that the antiseizure medication curbs appetite and enhances satiety through glutamate receptor antagonism.

Dr. McElroy consults for Ortho-McNeil Pharmaceutical Inc., the maker of topiramate.

Recommended Reading

Coitus May Be the Best Sexual Stress Reliever
MDedge Psychiatry
Many Cardiac Patients Going Untreated
MDedge Psychiatry
Link Between Depression, Mortality Weakened
MDedge Psychiatry
Psych Consult Delays Extend Hospital Stays
MDedge Psychiatry
Group Therapy Can Improve Viral Load in HIV
MDedge Psychiatry
PTSD Rate Highest in First Months After Brain Injury
MDedge Psychiatry
Secondary amenorrhea: Don’t dismiss it as ‘normal’
MDedge Psychiatry
Treating depression, chronic pain
MDedge Psychiatry
8 steps to manage recurrent abdominal pain
MDedge Psychiatry
Spotting a silent killer
MDedge Psychiatry